If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
350.60    6.20 (1.80%)
Bid:
348.80
Ask:
349.20
Spread: 0.40 (0.115%)
Market Cap: £2.55b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate Change

24 Mar 2020 07:00

RNS Number : 2923H
TP ICAP PLC
24 March 2020
 

TP ICAP plc (the "COMPANY")

FUTURE BOARD CHANGES

 

The Company announces that, for personal reasons, it is Ms Lorraine Trainer's intention not to seek re-election as a Director of the Company at its next Annual General Meeting to be held on 13 May 2020 ("AGM") and she will consequently be stepping down from the Board of the Company after that meeting.

 

On 27 September 2019, the Company announced that Ms Angela Knight CBE would not be seeking re-election as a Director of the Company at the AGM. However, in light of Ms Trainer's decision, TP ICAP is now pleased to announce that Ms Knight has agreed to remain on the Board and will therefore seek re-election as a Director of the Company at the AGM. Ms Knight will remain the Company's Senior Independent Director and will also assume the Chair of the Remuneration Committee, of which she has been a member for some years, with effect from 13 May 2020. It is expected that Ms Knight will remain on the Board at the latest until the 2021 Annual General Meeting.

 

Richard Berliand, Chairman of TP ICAP plc, said: "I'm very sorry that Lorraine has decided to step down from the Board. I'm most grateful for the contribution she has made to important Board discussions over almost two years, her leadership of the Remuneration Committee and her support to me since I became Chairman last year. I wish Lorraine the very best for the future.

 

"I'm delighted that Angela has agreed to remain on the Board for the near-term future. During these very uncertain times, her considerable knowledge and experience, not only from her time on the Company's Board, but also gained from her other current and previous roles and positions, mean that she will continue to be an invaluable counsel to me and other members of the Board as we navigate the challenges ahead and continue in our Non-executive Director searches."

 

 

ENDS

 

Richard Cordeschi

Group Company Secretary

Richard.Cordeschi@tpicap.com 

+44 (0) 20 7200 7331

 

For media enquiries please contact:

 

William Baldwin-Charles,

Group Media Relations Director

William.Baldwin-Charles@tpicap.com

+44 (0) 20 7200 7124

 

For investor enquiries please contact:

 

Al AlevizakosHead of Investor Relations and FP&AAlevizos.Alevizakos@tpicap.com

+44 (0) 20 3933 3040

 

 

About TP ICAP

 

TP ICAP brings together buyers and sellers in global financial, energy and commodities markets. It is the world's largest wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world. We operate from offices in 31 countries, supporting award-winning brokers with market-leading technology.

www.tpicap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAEDDAAXEEAA
Date   Source Headline
13th May 20207:00 amRNSTrading Update Q1 2020
12th May 20204:26 pmRNSHolding(s) in Company
23rd Apr 20204:30 pmRNSHolding(s) in Company
17th Apr 202012:09 pmRNSAnnual Financial Report
1st Apr 20207:00 amRNSDirector/PDMR Shareholding - Replacement
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20207:00 amRNSHolding(s) in Company
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.